08-16-2017, 09:05 PM
[attachment=4988]
Introduction
Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) is a neurotechnology innovator focused on the commercialization of two proprietary platforms for
direct neural sensing in the brain,
real-time neural signal decoding technology, and
neural stimulation.
Cyberkinetics has a Management Team and Board of Directors with proven track records at leading medical device and biotechnology companies. It is publicly traded on the Over the Counter Bulletin Board under the ticker symbol, CYKN.
The Company is headquartered in Foxborough, Massachusetts, and conducts engineering, research and manufacturing operations in Salt Lake City, Utah.
Introduction
Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) is a neurotechnology innovator focused on the commercialization of two proprietary platforms for
direct neural sensing in the brain,
real-time neural signal decoding technology, and
neural stimulation.
Cyberkinetics has a Management Team and Board of Directors with proven track records at leading medical device and biotechnology companies. It is publicly traded on the Over the Counter Bulletin Board under the ticker symbol, CYKN.
The Company is headquartered in Foxborough, Massachusetts, and conducts engineering, research and manufacturing operations in Salt Lake City, Utah.